Research Excellence

Our division is supported through a wide portfolio of funding mechanisms, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Biomedical Advanced Research and Development Authority (BARDA), State of Texas programs and industry collaborations.

Our faculty are nationally recognized leaders in:

Tuberculosis and Non-tuberculous Mycobacteria
Nocardiosis
Antimicrobial Resistance
Hollow Fiber Modeling
Clinical Diagnostics
Medical Education

Their work spans the spectrum of discovery and application—advancing scientific understanding, developing innovative diagnostics and therapies, and improving patient outcomes for complex infections.